ARS Pharmaceuticals, Inc. (SPRY)
8.615
-0.12
(-1.43%)
USD |
NASDAQ |
May 11, 16:00
8.615
0.00 (0.00%)
After-Hours: 19:33
ARS Pharmaceuticals Profit Margin (Quarterly) : -147.1% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 38.28% |
| Heron Therapeutics, Inc. | -7.28% |
| Krystal Biotech, Inc. | 48.07% |
| Century Therapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 1.36% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -91.12% |
| Return on Assets | -50.61% |
| Return on Invested Capital | -75.36% |
| Gross Profit Margin (Quarterly) | 78.09% |
| Operating Margin (Quarterly) | -147.6% |
| Return on Net Operating Assets | -370.6% |